Aurinia Pharmaceuticals Inc


Updates from The Motley Fool

Latest updates on Aurinia Pharmaceuticals from Fool.com.
3 Hot Biotech Stocks Now

Cara Therapeutics, Aurinia Pharmaceuticals, and Esperion Therapeutics are clinical-stage drug dev...



Stock Performance

View Interactive AUPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about Aurinia Pharmaceuticals.
Current Price: $8.02
Prev Close: $8.39
Open: $8.46
Bid: $8.20
Ask: $8.28
Day's Range: $7.76 - $8.51
52wk Range: $1.74 - $10.54
Volume: 8,311,267
Avg Vol 13,225,425
Market Cap: $629M
P/E (ttm): -12.71
EPS (ttm): ($0.66)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Aurinia Pharmaceuticals.
CAPS Rating 2 out of 5
 
19 Outperform
9 Underperform
CAPS All Stars
 
6 Outperform
4 Underperform

How do you think Aurinia Pharmaceuticals will perform against the market?



You pick for Aurinia Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Aurinia Pharmaceuticals.

Aurinia Pharmaceuticals Inc

  • Exchange: NASDAQ